Search Results - "Burkard ME"

Molecular Tumor Boards clinical impact on patient care and structural features: A systematic review and meta-analysis.

Authors: Russo, Luigi Giacobini, Erika Lentini, Nicolò et al.

Source: PLoS Medicine. 6/9/2026, Vol. 23 Issue 6, p1-30. 30p.

Anticancer Agents and Their Impact on Breast Reconstruction: A Guide for Plastic Surgeons Based on Systematic Review and Expert Consensus.

Authors: Zona EE Thornton SM Via EC et al.

Source: Plastic and reconstructive surgery [Plast Reconstr Surg] 2026 Feb 01; Vol. 157 (2), pp. 227-236. Date of Electronic Publication: 2025 Jul 22.

Publication Type: Journal Article; Systematic Review; Consensus Statement

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 1306050 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-4242 (Electronic) Linking ISSN: 00321052 NLM ISO Abbreviation: Plast Reconstr Surg Subsets: MEDLINE

A Patient-Led Survey of Antibody Drug Conjugate Usage and Dosing for People Living With Metastatic Breast Cancer.

Authors: Beumer A Carlson M Arcuri AL et al.

Source: Journal of patient experience [J Patient Exp] 2026 May 30; Vol. 13, pp. 23743735261457837. Date of Electronic Publication: 2026 May 30 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: United States NLM ID: 101688338 Publication Model: eCollection Cited Medium: Print ISSN: 2374-3735 (Print) Linking ISSN: 23743735 NLM ISO Abbreviation: J Patient Exp Subsets: PubMed not MEDLINE

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies.

Authors: Li BT Gandhi L Ravichandran V et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2026 Mar; Vol. 27 (2), pp. 214-226.e5. Date of Electronic Publication: 2025 Oct 01.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

Precision oncology's translation gap—Can molecular tumor boards bridge it?

Authors: Byrne, Margaret M. Kolesar, Jill M.

Source: PLoS Medicine. 6/30/2026, Vol. 23 Issue 6, p1-4. 4p.

Implementation of precision medicine in treating non-communicable diseases: a systematic review.

Authors: Liang, Shuang Kennedy, Elizabeth Gale, Nyree et al.

Source: Journal of Translational Medicine. 10/27/2025, Vol. 23 Issue 1, p1-14. 14p.

3D structure and stability prediction of DNA with multi-way junctions in ionic solutions.

Authors: Wang, Xunxun Shi, Ya-Zhou

Source: PLoS Computational Biology. 8/18/2025, Vol. 21 Issue 8, p1-23. 23p.

CINner: Modeling and simulation of chromosomal instability in cancer at single-cell resolution.

Authors: Dinh, Khanh N. Vázquez-García, Ignacio Chan, Andrew et al.

Source: PLoS Computational Biology. 4/3/2025, Vol. 21 Issue 4, p1-33. 33p.

Integrated transcriptomic and functional modeling reveals AKT and mTOR synergy in colorectal cancer.

Authors: Duleba, Marcin Zimoląg, Eliza Szuszkiewicz, Joanna et al.

Source: Scientific Reports. 7/31/2025, Vol. 15 Issue 1, p1-17. 17p.

Recent paclitaxel formulation strategies: expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations.

Authors: Lee J Choi MK Song IS

Source: Archives of pharmacal research [Arch Pharm Res] 2026 Apr; Vol. 49 (4), pp. 500-533. Date of Electronic Publication: 2026 Apr 10.

Publication Type: Journal Article; Review

Journal Info: Publisher: Pharmaceutical Society of Korea Country of Publication: Korea (South) NLM ID: 8000036 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1976-3786 (Electronic) Linking ISSN: 02536269 NLM ISO Abbreviation: Arch Pharm Res Subsets: MEDLINE

Surviving Twenty Years to Bone and Liver Metastatic Breast Cancer: A Case Reported by Treating Oncologists and the Patient Herself.

Authors: Valerio, Maria Rosaria Gebbia, Vittorio Piazza, Dario et al.

Source: Case Reports in Oncology. Oct2024, Vol. 17 Issue 1, p1174-1182. 9p. 1 Illustration.

This result is not displayed to guests.
Login for full access.

Diverse microtubule-targeted anticancer agents kill cells by inducing chromosome missegregation on multipolar spindles.

Authors: Zhou AS Tucker JB Scribano CM et al.

Source: PLoS biology [PLoS Biol] 2023 Oct 26; Vol. 21 (10), pp. e3002339. Date of Electronic Publication: 2023 Oct 26 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet ISSN: 1545-7885 (Electronic) Linking ISSN: 15449173 NLM ISO Abbreviation: PLoS Biol Subsets: MEDLINE

ARHGAP11A, a member of Rho GTPase activating protein family, as a prognostic biomarker linked to DNA damage response across pan-cancer.

Authors: Tan, Ke Wu, Yun Zhang, Jiaqi et al.

Source: BMC Cancer. 10/24/2025, Vol. 25 Issue 1, p1-11. 11p.

Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.

Authors: Ciliberto, Gennaro Canfora, Marco Terrenato, Irene et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 10/17/2022, Vol. 41 Issue 1, p1-5. 5p.

Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity.

Authors: Kratz JD Rehman S Johnson KA et al.

Source: Scientific reports [Sci Rep] 2025 Apr 09; Vol. 15 (1), pp. 12072. Date of Electronic Publication: 2025 Apr 09.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancer.

Authors: Di Cosimo, Serena Silvestri, Marco De Marco, Cinzia et al.

Source: Scientific Reports. 9/3/2024, Vol. 14 Issue 1, p1-8. 8p.

Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition.

Authors: Chapman, Isobel G. Wu, Xueqin Veuger, Stephany et al.

Source: PLoS ONE. 4/3/2026, Vol. 21 Issue 4, p1-17. 17p.

Expansion omics: from expansion microscopy to spatial omics.

Authors: Dong, Zhen Xiang, Weirong Jiang, Wenhao et al.

Source: Molecular Systems Biology. Feb2026, Vol. 22 Issue 2, p165-178. 14p.

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial.

Authors: Jhaveri K Eli LD Wildiers H et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Oct; Vol. 34 (10), pp. 885-898. Date of Electronic Publication: 2023 Aug 18.

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE